Stock Scorecard
Stock Summary for HCW Biologics Inc (HCWB) - $4.79 as of 7/17/2025 1:31:51 AM EST
Total Score
7 out of 30
Safety Score
16 out of 100
Currently on the following lists
Small Cap Stock List
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for HCWB
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for HCWB
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for HCWB
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for HCWB
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for HCWB (16 out of 100)
| Stock Price Rating (Max of 10) | 3 |
| Historical Stock Price Rating (Max of 10) | 9 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 2 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for HCWB
Financial Details for HCWB
Company Overview |
|
|---|---|
| Ticker | HCWB |
| Company Name | HCW Biologics Inc |
| Country | USA |
| Description | N/A |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 3/31/2025 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 4.79 |
| Price 4 Years Ago | 92.80 |
| Last Day Price Updated | 7/17/2025 1:31:51 AM EST |
| Last Day Volume | 32,304 |
| Average Daily Volume | 174,640 |
| 52-Week High | 62.40 |
| 52-Week Low | 3.55 |
| Last Price to 52 Week Low | 34.93% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 22.12 |
| Sector PE | 40.31 |
| 5-Year Average PE | -112.84 |
| Free Cash Flow Ratio | 239.50 |
| Industry Free Cash Flow Ratio | 18.49 |
| Sector Free Cash Flow Ratio | 32.75 |
| Current Ratio Most Recent Quarter | 0.07 |
| Total Cash Per Share | 0.02 |
| Book Value Per Share Most Recent Quarter | -7.62 |
| Price to Book Ratio | 2.80 |
| Industry Price to Book Ratio | 34.63 |
| Sector Price to Book Ratio | 31.07 |
| Price to Sales Ratio Twelve Trailing Months | 7.66 |
| Industry Price to Sales Ratio Twelve Trailing Months | 140.85 |
| Sector Price to Sales Ratio Twelve Trailing Months | 40.56 |
| Analyst Buy Ratings | N/A |
| Analyst Strong Buy Ratings | N/A |
Share Statistics |
|
| Total Shares Outstanding | 44,675,700 |
| Market Capitalization | 213,996,603 |
| Institutional Ownership | 1.47% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -20.12% |
| Reported EPS 12 Trailing Months | -24.80 |
| Reported EPS Past Year | -0.05 |
| Reported EPS Prior Year | -7.68 |
| Net Income Twelve Trailing Months | -24,752,627 |
| Net Income Past Year | -30,023,814 |
| Net Income Prior Year | -24,994,277 |
| Quarterly Revenue Growth YOY | -99.60% |
| 5-Year Revenue Growth | 123.81% |
| Operating Margin Twelve Trailing Months | -78,298.00% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 1,107,613 |
| Total Cash Past Year | 4,674,572 |
| Total Cash Prior Year | 3,595,101 |
| Net Cash Position Most Recent Quarter | -6,597,751 |
| Net Cash Position Past Year | -2,703,293 |
| Long Term Debt Past Year | 7,377,865 |
| Long Term Debt Prior Year | 6,304,318 |
| Total Debt Most Recent Quarter | 7,705,364 |
| Equity to Debt Ratio Past Year | -11.14 |
| Equity to Debt Ratio Most Recent Quarter | 0.00 |
| Total Stockholder Equity Past Year | -6,770,172 |
| Total Stockholder Equity Prior Year | 13,461,717 |
| Total Stockholder Equity Most Recent Quarter | -8,562,048 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -14,306,456 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.32 |
| Free Cash Flow Past Year | -14,489,045 |
| Free Cash Flow Prior Year | -28,716,721 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | False |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.55 |
| MACD Signal | -0.70 |
| 20-Day Bollinger Lower Band | 1.69 |
| 20-Day Bollinger Middle Band | 7.86 |
| 20-Day Bollinger Upper Band | 14.03 |
| Beta | 0.84 |
| RSI | 41.19 |
| 50-Day SMA | 49.63 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 62.15 |
System |
|
| Modified | 7/17/2025 1:31:52 AM EST |